Abstract
Key features
• Occurs worldwide
• Prevalence in developing countries >80%
• Mainly acquired in childhood, persisting for life
• Associated with chronic gastritis, peptic ulcer disease, gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma
• Defined by the World Health Organization (WHO) as class I carcinogen
• Diagnosed by variety of invasive and noninvasive methods
• Consensus guidelines exist regarding indications for treatment and treatment regimens
• Treatment requires multiday combination antibiotic therapy
• No vaccine is currently available
• Occurs worldwide
• Prevalence in developing countries >80%
• Mainly acquired in childhood, persisting for life
• Associated with chronic gastritis, peptic ulcer disease, gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma
• Defined by the World Health Organization (WHO) as class I carcinogen
• Diagnosed by variety of invasive and noninvasive methods
• Consensus guidelines exist regarding indications for treatment and treatment regimens
• Treatment requires multiday combination antibiotic therapy
• No vaccine is currently available
| Original language | English |
|---|---|
| Title of host publication | Hunter's Tropical Medicine and Emerging Infectious Disease |
| Subtitle of host publication | Ninth Edition |
| Editors | Alan J. Magill, David R. Hill, Tom Solomon, Edward T. Ryan |
| Chapter | 41 |
| Pages | 437-441 |
| Number of pages | 5 |
| Edition | Ninth edition |
| DOIs | |
| Publication status | Published - 2013 |
Bibliographical note
Copyright © 2013 Elsevier Inc. All rights reserved.UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Helicobacter pylori Infection'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver